Double Placebo
Sponsors
National Institute on Alcohol Abuse and Alcoholism (NIAAA), University of Sao Paulo, Pluristem Ltd., Mayo Clinic, University of Minnesota
Conditions
Alcohol DependenceCancerDepressionDepressive Disorder, MajorHaematological Disorders
Nutritional, Metabolic, Endocrine
Menstruation, anaemiaHeart Failure, Preserved Ejection FractionHivHysterosalpingography
Phase 1
Phase 2
Aripiprazole and Topiramate on Free-Choice Alcohol Use
CompletedNCT00884884
Start: 2007-09-30End: 2015-10-31Updated: 2015-10-07
Efficacy Study of Transcranial Direct Current Stimulation to Treat Major Depressive Disorder
CompletedNCT01033084
Start: 2009-12-31End: 2011-12-31Updated: 2011-12-06
Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)
CompletedNCT01679990
Start: 2012-11-05End: 2019-02-09Updated: 2019-02-12
Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT
TerminatedNCT02619812
Start: 2016-04-30End: 2016-12-31Updated: 2017-06-14
Clinical Trials to Evaluate Metformin to Treat Depression in People Living With HIV
WithdrawnNCT07007221
Start: 2026-07-01End: 2030-12-01Updated: 2026-07-10
Phase 3
A study will evaluate the efficacy and safety of tiragolumab plus atezolizumab compared with placebo in patients with unresectable esophageal squamous cell carcinoma (or those who are unable or unwilling to undergo surgery) and whose cancers have not progressed following definitive concurrent chemoradiotherapy (dCRT).
Active, not recruitingPACTR202201585469592
Start: 2022-03-31Target: 750Updated: 2026-08-03
Effect of ibuprofen and multiple micronutrient supplementation on menstrual blood loss and iron stores in menstruating Malawian adolescent girls: a 2x2 factorial, randomized controlled trial (the SPIRIT Trial)
Active, not recruitingPACTR202408544495075
Start: 2024-10-01Target: 450Updated: 2026-09-14